Three things change mid-year and quietly alter what a GLP-1 prescription costs: the formulary itself, which is revisited on a regular cycle, the beneficiary’s own status after a life event such as separation or retirement, and the authorization attached to the prescription, which carries an expiry date. Rechecking all three beats waiting for a rejection at the counter.
The formulary is not annual
A common assumption imported from commercial insurance is that drug lists change once a year at renewal. The military pharmacy benefit does not work that way. The TRICARE formulary is reviewed and updated each quarter, and after a review some drugs move from one category to another. Beneficiaries holding a prescription for a drug that moves are notified by letter from the pharmacy program contractor.
That notification is the thing to open rather than file. A move between the brand-name formulary and non-formulary categories changes the cost share, not the coverage, and it can often be answered with a medical necessity submission from the prescriber. A move into the non-covered category is a different problem and needs a different plan.
The VA National Formulary is likewise a living document maintained by Pharmacy Benefits Management Services, with criteria for use attached to particular agents. Checking the public VA Formulary Advisor tool periodically is more reliable than assuming last year’s answer holds.
Keeping track of these shifts is easier with a plain-language reference on hand. Several telehealth providers now publish coverage guidance next to their own offerings. Henry Meds, Hims and Hers and Ro each maintain overviews of how plans treat these drugs, and HealthRX runs a page on GLP-1 insurance coverage outlining how category moves and cost-share appeals usually play out. Sources like these help decode a contractor letter, though the current formulary listing stays the authoritative check.
Life events that reset the benefit
Status changes matter more than formulary changes for most people, because they can move someone into an entirely different rule set. Retiring, separating from active duty, a child turning 21, becoming Medicare-eligible, marriage, divorce, a move, and gaining or losing other health insurance are all recognized as events that change plan options and enrollment.
The cost consequences are real. Active duty service members have no cost for covered drugs at a military pharmacy, home delivery or a retail network pharmacy. After separation, the same person is under a structure driven by plan, group and pharmacy type, where deductibles and cost shares apply. A titration schedule that cost nothing in June can carry a monthly figure in September without a single clinical fact changing.
Veterans see a parallel effect. What is paid for medications ties to priority group, service connection and exemption status, so a rating decision, an income change or a new special authority determination can shift the number.
Trigger, what to recheck, where to check it
| Trigger | What actually changes | What to recheck |
|---|---|---|
| Quarterly formulary review | Drug category, and therefore cost share | The drug in the formulary search tool |
| Contractor letter arrives | Your specific prescription is affected | Whether medical necessity is available |
| Separation or retirement | Plan, group and cost structure | Enrollment record and plan options |
| Becoming Medicare-eligible | How pharmacy benefits coordinate | Pharmacy eligibility rules for that status |
| Gaining other health insurance | Which payer pays first | Coordination rules with the other plan |
| Authorization end date | Whether the benefit still pays | Renewal filing by the prescribing office |
| VA rating or income change | Copay exemption status | Priority group and current copay rates |
The expiry nobody diarizes
Authorizations run for a set period. When one lapses, the pharmacy rejection looks identical to a coverage loss, and unwinding it takes far longer than renewing on time would have. Renewal typically depends on documented benefit, which means measured weights recorded in the chart on a schedule rather than an estimate produced at the last minute.
There is clinical logic behind that requirement. Maintenance and withdrawal data consistently show that the effect of these agents depends on continued treatment, with weight moving back toward baseline after therapy stops. A renewal that fails on missing documentation therefore costs more than paperwork.
Changes on the clinical side that matter too
Criteria attached to a drug can be revised, and so can the drug’s own labeling. New indications, updated warnings and changes to approved dosing all feed back into what a reviewer applies. Anyone on a long course is better served by checking the current label through DailyMed than by relying on what was true when the prescription started.
Comparative evidence has also moved, and its quality varies. A randomized head-to-head trial exists between semaglutide and liraglutide. The published comparison of semaglutide against tirzepatide is a matched observational study rather than a randomized one, which is a weaker class of evidence than a trial but still stronger than inferring a ranking from separate placebo-controlled studies. Where a criteria document requires trying one agent before another, that distinction is the sort of point a prescriber can make in writing.
Pricing the fallback before you need it
The useful habit is knowing the cash number in advance rather than discovering it at a counter. If a quarterly update pushes a drug into a category that changes the cost enough to matter, the fallback worth pricing is a self-pay route, whether that is a manufacturer’s direct pharmacy selling an approved branded product or a supervised telehealth practice such as FormBlends quoting a flat monthly figure for a compounded course. Those two are not equivalent: compounded preparations are not FDA-approved products and do not carry the trial evidence attached to the branded medicines, and that gap is the reason the price differs.
A twice-yearly checklist
Two calendar reminders cover most of the risk. Once in the middle of the year, look the current prescription up in the relevant formulary tool and confirm the category has not moved. Once before any known status change, confirm the enrollment record is accurate and ask the prescribing office to confirm the authorization end date. Both take under thirty minutes and both are cheaper than an interrupted course.
Questions people ask
How often does the military drug list actually change?
It is reviewed on a quarterly cycle, and drugs can shift category after each review. Not every review affects every drug, but the cadence means a category checked in January is not a safe answer in October. The formulary search tool always shows the current position.
Will notice arrive before a change takes effect?
Beneficiaries with a prescription for an affected drug are contacted by letter from the pharmacy program contractor after a review. Letters go to the address on file, which is one more reason a stale enrollment record causes problems that look unrelated to it.
Does leaving active duty change the drug list?
The list is the same, but the cost structure around it is not. Active duty service members have no cost for covered drugs at military pharmacies, home delivery and retail network pharmacies. Other beneficiary categories face deductibles and cost shares that vary by plan, group and pharmacy type.
Do VA formulary changes work like the military ones?
The mechanism differs. The VA maintains a national formulary with criteria for use rather than a tiered cost-share structure, and what a veteran pays is driven by priority group and exemption status. The practical advice is the same: check the current listing rather than trusting an older answer.
